Stocksigma LogoStocksigma Logo

Q-Line Biotech Schedules Board Meeting for 16th AGM Approvals and Cost Auditor Appointment

Q-Line Biotech Limited has scheduled a Board of Directors meeting on 5th Sep'26 to consider and approve key corporate actions

Q-Line Biotech Schedules Board Meeting for 16th AGM Approvals and Cost Auditor Appointment

Q-Line Biotech Ltd 路 Others (Uncategorized) 路 05 Sept 2026, 12:39 am

Q-Line Biotech Schedules Board Meeting for 16th AGM Approvals and Cost Auditor Appointment Q-Line Biotech Limited has scheduled a Board of Directors meeting on 5th Sep'26 to consider and approve key corporate actions. The agenda includes approving the Directors' Report for the financial year ended 31st Mar'26, finalising the notice and schedule for the 16th Annual General Meeting, fixing the cut-off date for e-voting, and recommending director appointments. Additionally, the board will evaluate the appointment and remuneration of M/s P S P & Associates as Cost Auditor for FY 2026-27, subject to shareholder ratification.

Original exchange filing (PDF)

More announcements from Q-Line Biotech Ltd

All Q-Line Biotech Ltd announcements